Given the vital role of XRCC4 in DNA repair and chemoresistance, understanding the significance of its SUMOylation could have profound implications in overcoming therapeutic resistance in pancreatic cancer. This evidence concerns the gene XRCC4 and familial pancreatic carcinoma.